LEVOTHYROXINE SODIUM ANHYDROUS

LEVOTHYROXINE SODIUM ANHYDROUS was reported 101639 times

LEVOTHYROXINE SODIUM ANHYDROUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 353 0.6326
1 IMMUNISATION 231 0.5323
2 PALMOPLANTAR KERATODERMA 348 0.4800
3 EJECTION FRACTION 174 0.2995
4 SENSITISATION 221 0.2912
5 TOTAL LUNG CAPACITY ABNORMAL 107 0.2751
6 C-REACTIVE PROTEIN 233 0.2513
7 NEUROLOGIC NEGLECT SYNDROME 137 0.2464
8 PULMONARY VASCULITIS 132 0.2454
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 400 0.1997
10 SEDATION COMPLICATION 483 0.1891
11 ATRIAL TACHYCARDIA 371 0.1765
12 MULTIPLE DRUG THERAPY 133 0.1764
13 SPIROMETRY ABNORMAL 99 0.1656
14 MITE ALLERGY 107 0.1634
15 CAROTID ARTERY THROMBOSIS 138 0.1625
16 PRURITUS GENITAL 357 0.1515
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 101 0.1512
18 POLYCYSTIC OVARIES 222 0.1430
19 LUPUS VULGARIS 179 0.1421
20 CREATININE RENAL CLEARANCE DECREASED 526 0.1313
21 CATARRH 112 0.1239
22 SWOLLEN JOINT COUNT INCREASED 394 0.1234
23 MYCOTIC ALLERGY 103 0.1205
24 SCHIZOAFFECTIVE DISORDER 213 0.1193
25 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 110 0.1187
26 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 86 0.1173
27 STEROID DEPENDENCE 101 0.1150
28 X-RAY ABNORMAL 192 0.1073
29 DUST ALLERGY 105 0.1070
30 ADJUSTMENT DISORDER 134 0.1031
31 CAROTID ARTERY OCCLUSION 374 0.1024
32 RHEUMATIC FEVER 452 0.1013
33 SYSTEMIC INFECTION 163 0.0983
34 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 187 0.0902
35 NEURITIS 139 0.0900
36 TENSION HEADACHE 387 0.0899
37 SLEEP TERROR 360 0.0854
38 PRODUCT MONITORING ERROR 123 0.0851
39 CONJUNCTIVITIS ALLERGIC 123 0.0830
40 RHEUMATOID FACTOR POSITIVE 433 0.0749
41 C-REACTIVE PROTEIN ABNORMAL 473 0.0737
42 FACET JOINT SYNDROME 221 0.0678
43 BURNS SECOND DEGREE 117 0.0666
44 DISLOCATION OF VERTEBRA 149 0.0653
45 RHINITIS ALLERGIC 288 0.0646
46 EJECTION FRACTION ABNORMAL 79 0.0644
47 DUODENAL ULCER PERFORATION 476 0.0639
48 BLOOD THYROID STIMULATING HORMONE ABNORMAL 116 0.0629
49 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 447 0.0623
50 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 127 0.0622
51 BLOOD THYROID STIMULATING HORMONE INCREASED 570 0.0619
52 RESPIRATORY DISORDER NEONATAL 100 0.0617
53 PERSONALITY DISORDER 155 0.0591
54 PERIPHERAL VENOUS DISEASE 238 0.0582
55 TOTAL LUNG CAPACITY DECREASED 92 0.0576
56 OBSTRUCTIVE SLEEP APNOEA SYNDROME 83 0.0569
57 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 366 0.0563
58 RESPIRATORY SYMPTOM 158 0.0555
59 RETINITIS 92 0.0532
60 HYPOTHYROIDISM 1698 0.0531
61 BLOOD CALCIUM DECREASED 597 0.0530
62 PITUITARY TUMOUR BENIGN 83 0.0509
63 PERICARDITIS 835 0.0496
64 MUSCLE INJURY 411 0.0496
65 NORMOCHROMIC NORMOCYTIC ANAEMIA 148 0.0492
66 FACIAL PAIN 438 0.0490
67 BLOOD THYROID STIMULATING HORMONE DECREASED 221 0.0486
68 VASCULITIS 558 0.0479
69 PLEURITIC PAIN 131 0.0474
70 EYELID PAIN 96 0.0472
71 ORTHOSTATIC HYPOTENSION 819 0.0470
72 SUBARACHNOID HAEMORRHAGE 478 0.0469
73 HELICOBACTER INFECTION 475 0.0462
74 FULL BLOOD COUNT ABNORMAL 487 0.0460
75 THYROID FUNCTION TEST ABNORMAL 188 0.0452
76 AUTOIMMUNE DISORDER 430 0.0441
77 NASAL OBSTRUCTION 82 0.0437
78 DRUG TOLERANCE DECREASED 120 0.0427
79 SCIATICA 665 0.0417
80 LIP DRY 373 0.0410
81 FOLLICULITIS 421 0.0401
82 RECALLED PRODUCT ADMINISTERED 381 0.0399
83 LUNG OPACITY 103 0.0390
84 CYTOLYTIC HEPATITIS 127 0.0382
85 HAND DEFORMITY 490 0.0373
86 ALCOHOL POISONING 100 0.0373
87 HYPOPNOEA 128 0.0368
88 BURSITIS 445 0.0366
89 LIVE BIRTH 303 0.0362
90 FORCED EXPIRATORY VOLUME DECREASED 101 0.0356
91 PEMPHIGUS 444 0.0355
92 ARTERIOSCLEROSIS CORONARY ARTERY 234 0.0353
93 BRONCHIECTASIS 234 0.0347
94 FIBROMYALGIA 813 0.0334
95 AUTOIMMUNE THYROIDITIS 125 0.0330
96 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 559 0.0329
97 PULMONARY FIBROSIS 630 0.0328
98 VENTRICULAR TACHYCARDIA 538 0.0325
99 BLOOD TEST ABNORMAL 443 0.0315
100 HYPERTHYROIDISM 456 0.0315
101 JOINT RANGE OF MOTION DECREASED 416 0.0310
102 RALES 179 0.0308
103 SYNOVITIS 555 0.0307
104 GESTATIONAL DIABETES 146 0.0306
105 CARDIAC MURMUR 261 0.0301
106 OBSTRUCTIVE AIRWAYS DISORDER 335 0.0301
107 BREAST CANCER STAGE III 193 0.0298
108 THERAPEUTIC AGENT TOXICITY 99 0.0297
109 GANGRENE 178 0.0295
110 ANOSMIA 418 0.0288
111 NEUROLOGICAL SYMPTOM 162 0.0283
112 COGNITIVE DISORDER 1320 0.0282
113 SEASONAL ALLERGY 397 0.0280
114 INFUSION SITE HAEMORRHAGE 92 0.0279
115 LOWER LIMB FRACTURE 534 0.0278
116 WOUND INFECTION 298 0.0272
117 RENAL FUNCTION TEST ABNORMAL 126 0.0271
118 THROAT CLEARING 101 0.0269
119 BONE EROSION 95 0.0268
120 RHINITIS 216 0.0268
121 SEDATION 698 0.0266
122 GRIP STRENGTH DECREASED 233 0.0264
123 PULMONARY ALVEOLAR HAEMORRHAGE 148 0.0264
124 GLOSSODYNIA 580 0.0259
125 MULTIPLE ALLERGIES 202 0.0257
126 GOITRE 103 0.0251
127 ARTERIAL OCCLUSIVE DISEASE 197 0.0250
128 SENSORY LOSS 201 0.0249
129 CARPAL TUNNEL SYNDROME 346 0.0247
130 SMALL FOR DATES BABY 121 0.0244
131 THYROID DISORDER 375 0.0243
132 TYPE 2 DIABETES MELLITUS 808 0.0240
133 ATRIAL SEPTAL DEFECT 200 0.0239
134 IRRITABLE BOWEL SYNDROME 509 0.0237
135 HYPERCHOLESTEROLAEMIA 229 0.0237
136 WALKING AID USER 156 0.0236
137 BLOOD PRESSURE INADEQUATELY CONTROLLED 141 0.0234
138 RED BLOOD CELL SEDIMENTATION RATE INCREASED 255 0.0230
139 MATERNAL EXPOSURE TIMING UNSPECIFIED 86 0.0229
140 WHEEZING 1356 0.0228
141 INFUSION SITE SWELLING 143 0.0227
142 ARTERIOSCLEROSIS 213 0.0226
143 ATRIOVENTRICULAR BLOCK FIRST DEGREE 98 0.0226
144 DIPLOPIA 587 0.0226
145 ULCER HAEMORRHAGE 151 0.0223
146 OBESITY 354 0.0222
147 MUSCLE TWITCHING 511 0.0221
148 EXERCISE TOLERANCE DECREASED 127 0.0220
149 MOBILITY DECREASED 1584 0.0220
150 GINGIVAL PAIN 175 0.0220
151 SLEEP APNOEA SYNDROME 419 0.0219
152 WOUND 613 0.0219
153 BUNDLE BRANCH BLOCK LEFT 93 0.0219
154 PAROSMIA 165 0.0218
155 MOTOR DYSFUNCTION 219 0.0215
156 DEPRESSED LEVEL OF CONSCIOUSNESS 847 0.0214
157 HEMIPLEGIA 178 0.0214
158 TRANSIENT ISCHAEMIC ATTACK 721 0.0213
159 BLOOD CALCIUM INCREASED 186 0.0212
160 RENAL FAILURE CHRONIC 160 0.0208
161 SINUS CONGESTION 281 0.0208
162 LIVER INJURY 510 0.0208
163 INFUSION SITE ERYTHEMA 174 0.0206
164 INFUSION SITE PAIN 265 0.0205
165 SPUTUM DISCOLOURED 195 0.0205
166 AFFECT LABILITY 197 0.0205
167 GENERAL PHYSICAL HEALTH DETERIORATION 2361 0.0204
168 ERYSIPELAS 101 0.0201
169 HYPONATRAEMIA 1129 0.0200
170 RENAL FAILURE ACUTE 849 0.0200
171 MUSCLE SPASTICITY 244 0.0198
172 BUNDLE BRANCH BLOCK RIGHT 90 0.0196
173 AORTIC VALVE INCOMPETENCE 83 0.0195
174 SYSTEMIC LUPUS ERYTHEMATOSUS 687 0.0193
175 ASPIRATION 208 0.0190
176 VASCULAR DEVICE INFECTION 86 0.0189
177 MITRAL VALVE INCOMPETENCE 214 0.0189
178 BLOOD CHOLESTEROL INCREASED 880 0.0189
179 PRESCRIBED OVERDOSE 365 0.0188
180 COORDINATION ABNORMAL 263 0.0188
181 CONTRAINDICATED PRODUCT ADMINISTERED 564 0.0186
182 OEDEMA 1003 0.0185
183 NIGHT SWEATS 594 0.0184
184 TINNITUS 846 0.0184
185 OSTEOARTHRITIS 777 0.0183
186 DYSPNOEA EXERTIONAL 689 0.0183
187 LUNG DISORDER 893 0.0182
188 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 161 0.0182
189 LIP SWELLING 606 0.0182
190 RESPIRATORY TRACT CONGESTION 289 0.0182
191 ADRENAL INSUFFICIENCY 220 0.0181
192 LOWER RESPIRATORY TRACT INFECTION 821 0.0180
193 SKIN HAEMORRHAGE 267 0.0180
194 COLITIS MICROSCOPIC 85 0.0179
195 RASH PAPULAR 402 0.0179
196 GASTROINTESTINAL MOTILITY DISORDER 95 0.0177
197 OEDEMA PERIPHERAL 2162 0.0177
198 IMPAIRED HEALING 578 0.0176
199 DIABETIC NEUROPATHY 87 0.0176
200 DRUG LEVEL INCREASED 290 0.0175
201 INTERNATIONAL NORMALISED RATIO INCREASED 498 0.0174
202 HYPERNATRAEMIA 87 0.0174
203 HYPERVOLAEMIA 86 0.0174
204 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 88 0.0174
205 HIP ARTHROPLASTY 266 0.0174
206 IRON DEFICIENCY 78 0.0173
207 SINUS DISORDER 342 0.0173
208 LIVER DISORDER 760 0.0171
209 PAIN OF SKIN 458 0.0170
210 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 813 0.0169
211 AMNESIA 1101 0.0169
212 BREATH SOUNDS ABNORMAL 83 0.0168
213 EYE PRURITUS 564 0.0168
214 ANGINA PECTORIS 479 0.0167
215 PRESCRIBED UNDERDOSE 331 0.0166
216 HEMIPARESIS 279 0.0165
217 EYE PAIN 924 0.0164
218 CYSTITIS 520 0.0163
219 ELECTROCARDIOGRAM QT PROLONGED 587 0.0163
220 BLOOD UREA INCREASED 272 0.0162
221 SINUSITIS 1656 0.0161
222 HYPERLIPIDAEMIA 193 0.0161
223 CACHEXIA 83 0.0161
224 TYPE 1 DIABETES MELLITUS 97 0.0161
225 VITAMIN D DEFICIENCY 157 0.0161
226 ELECTROCARDIOGRAM ABNORMAL 126 0.0160
227 ASTHMA 1813 0.0160
228 PHARYNGOLARYNGEAL PAIN 85 0.0160
229 PALPITATIONS 1873 0.0160
230 HAEMOPTYSIS 444 0.0159
231 EXOSTOSIS 145 0.0159
232 BALANCE DISORDER 1370 0.0158
233 GASTROOESOPHAGEAL REFLUX DISEASE 1273 0.0158
234 EAR PAIN 306 0.0157
235 DIVERTICULUM 111 0.0156
236 BLISTER 877 0.0156
237 PSORIATIC ARTHROPATHY 633 0.0156
238 TACHYCARDIA 1383 0.0156
239 VENTRICULAR SEPTAL DEFECT 89 0.0155
240 GAIT INABILITY 518 0.0155
241 GRANULOCYTOPENIA 88 0.0154
242 UPPER-AIRWAY COUGH SYNDROME 127 0.0154
243 HYPOMAGNESAEMIA 214 0.0154
244 HYPOKALAEMIA 708 0.0153
245 MALABSORPTION 80 0.0153
246 GAMMA-GLUTAMYLTRANSFERASE INCREASED 338 0.0152
247 ANOREXIA 196 0.0152
248 HAEMATOCRIT DECREASED 300 0.0151
249 MUSCULAR WEAKNESS 1717 0.0151
250 STOMATITIS 916 0.0151
251 ELECTROLYTE IMBALANCE 175 0.0150
252 LYMPHOEDEMA 104 0.0150
253 C-REACTIVE PROTEIN INCREASED 547 0.0150
254 MUSCULOSKELETAL PAIN 785 0.0150
255 TRICUSPID VALVE INCOMPETENCE 119 0.0150
256 DRY MOUTH 1213 0.0149
257 DISTURBANCE IN ATTENTION 806 0.0149
258 WEIGHT FLUCTUATION 155 0.0148
259 HYPOXIA 521 0.0148
260 BLEPHAROSPASM 93 0.0148
261 JOINT DISLOCATION 156 0.0147
262 PROTHROMBIN TIME PROLONGED 88 0.0147
263 SPINAL OSTEOARTHRITIS 129 0.0147
264 HIATUS HERNIA 190 0.0147
265 BREAST CANCER STAGE II 122 0.0146
266 CATARACT OPERATION 87 0.0146
267 HEPATIC STEATOSIS 273 0.0146
268 BLOOD SODIUM DECREASED 274 0.0145
269 PRODUCTIVE COUGH 693 0.0145
270 IRON DEFICIENCY ANAEMIA 133 0.0144
271 CHOKING SENSATION 79 0.0143
272 ANGIOEDEMA 632 0.0143
273 OESOPHAGITIS 156 0.0143
274 ROAD TRAFFIC ACCIDENT 597 0.0143
275 SNEEZING 320 0.0143
276 DEHYDRATION 1901 0.0142
277 CHOLECYSTITIS CHRONIC 95 0.0142
278 HYPERKALAEMIA 496 0.0141
279 KNEE ARTHROPLASTY 297 0.0141
280 HYPERTRANSAMINASAEMIA 98 0.0141
281 EATING DISORDER 300 0.0141
282 DRUG INTERACTION 2234 0.0141
283 APHASIA 423 0.0140
284 LUPUS-LIKE SYNDROME 127 0.0140
285 CONFUSIONAL STATE 2252 0.0139
286 ARTHROPATHY 774 0.0139
287 OLIGURIA 85 0.0137
288 SLEEP DISORDER 964 0.0136
289 BLOOD CREATININE INCREASED 889 0.0136
290 BLOOD ALBUMIN DECREASED 108 0.0136
291 VENTRICULAR EXTRASYSTOLES 141 0.0136
292 POLYURIA 111 0.0135
293 SINUS BRADYCARDIA 131 0.0135
294 BLOOD POTASSIUM INCREASED 220 0.0135
295 HEPATIC ENZYME INCREASED 923 0.0135
296 HYPERCALCAEMIA 167 0.0135
297 TROPONIN INCREASED 102 0.0134
298 CONTUSION 1290 0.0134
299 ATRIAL FIBRILLATION 1304 0.0134
300 HYPERTENSION 2836 0.0134
301 CIRCULATORY COLLAPSE 228 0.0134
302 BRADYCARDIA 710 0.0134
303 PREGNANCY 268 0.0134
304 PRODUCT PRESCRIBING ERROR 318 0.0133
305 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 137 0.0133
306 HYPOTENSION 2674 0.0133
307 GASTROINTESTINAL DISORDER 1194 0.0133
308 MICTURITION URGENCY 152 0.0133
309 LEFT VENTRICULAR DYSFUNCTION 89 0.0133
310 THERAPY NON-RESPONDER 597 0.0133
311 INITIAL INSOMNIA 136 0.0132
312 MUSCULOSKELETAL STIFFNESS 1159 0.0132
313 TRANSAMINASES INCREASED 294 0.0132
314 UPPER RESPIRATORY TRACT INFECTION 610 0.0132
315 INTERVERTEBRAL DISC DEGENERATION 122 0.0132
316 FOREIGN BODY SENSATION IN EYES 84 0.0132
317 HYPERGLYCAEMIA 480 0.0132
318 BLOOD PRESSURE DIASTOLIC DECREASED 97 0.0131
319 DELIRIUM 456 0.0131
320 HYPOCALCAEMIA 248 0.0131
321 OCULAR DISCOMFORT 147 0.0131
322 MYOPATHY 113 0.0131
323 BLOOD ALKALINE PHOSPHATASE INCREASED 324 0.0130
324 MIGRAINE 1245 0.0130
325 HYPERTENSIVE CRISIS 145 0.0130
326 TUBULOINTERSTITIAL NEPHRITIS 244 0.0130
327 SWOLLEN TONGUE 405 0.0130
328 TENDERNESS 135 0.0129
329 ABDOMINAL DISCOMFORT 2170 0.0129
330 BLINDNESS 527 0.0129
331 GRAND MAL CONVULSION 119 0.0129
332 RESPIRATORY TRACT INFECTION 335 0.0128
333 HOSPICE CARE 127 0.0128
334 NAIL DISORDER 112 0.0128
335 SKIN LACERATION 139 0.0128
336 CONSTIPATION 2785 0.0128
337 BLOOD MAGNESIUM DECREASED 110 0.0127
338 CHEST PAIN 2358 0.0127
339 GASTRITIS 335 0.0127
340 NODULE 166 0.0127
341 DIABETES MELLITUS INADEQUATE CONTROL 225 0.0127
342 PHOTOPHOBIA 239 0.0127
343 HEPATIC CIRRHOSIS 238 0.0127
344 ONYCHOCLASIS 87 0.0126
345 DERMATITIS CONTACT 144 0.0126
346 EXTRASYSTOLES 88 0.0126
347 RENAL CYST 100 0.0126
348 DISCOMFORT 766 0.0125
349 ABDOMINAL PAIN UPPER 2569 0.0125
350 FALL 4135 0.0124
351 LIPASE INCREASED 95 0.0124
352 THERAPEUTIC PRODUCT EFFECT DECREASED 550 0.0123
353 MEDICATION ERROR 682 0.0123
354 PULMONARY HYPERTENSION 255 0.0122
355 HAEMATOMA 317 0.0122
356 GLOMERULAR FILTRATION RATE DECREASED 150 0.0122
357 CARDIOMEGALY 150 0.0122
358 DYSARTHRIA 459 0.0122
359 GOUT 218 0.0121
360 ATELECTASIS 117 0.0121
361 ATRIOVENTRICULAR BLOCK COMPLETE 81 0.0121
362 BLOOD PRESSURE SYSTOLIC INCREASED 235 0.0120
363 ARTHRITIS 946 0.0120
364 RHABDOMYOLYSIS 501 0.0120
365 HEPATITIS ACUTE 78 0.0120
366 DRUG INTOLERANCE 1158 0.0120
367 DISORIENTATION 475 0.0120
368 PETECHIAE 125 0.0120
369 VERTIGO 728 0.0119
370 CHOLECYSTITIS 142 0.0119
371 PLEURAL EFFUSION 723 0.0119
372 ORAL PAIN 266 0.0119
373 INFLAMMATION 612 0.0118
374 TEMPERATURE INTOLERANCE 122 0.0118
375 PEMPHIGOID 89 0.0118
376 HALLUCINATION 886 0.0117
377 UROSEPSIS 108 0.0117
378 LIVER FUNCTION TEST ABNORMAL 340 0.0117
379 BODY HEIGHT DECREASED 125 0.0117
380 ATRIAL FLUTTER 93 0.0116
381 RECTAL HAEMORRHAGE 500 0.0116
382 ASTHENIA 4372 0.0116
383 COELIAC DISEASE 114 0.0116
384 PERIPHERAL SWELLING 1789 0.0116
385 HAEMATOCHEZIA 639 0.0116
386 RHEUMATOID ARTHRITIS 1313 0.0116
387 DIZZINESS POSTURAL 112 0.0115
388 SHOCK HAEMORRHAGIC 94 0.0115
389 HYPOGLYCAEMIA 560 0.0115
390 PURPURA 102 0.0115
391 RENAL DISORDER 536 0.0115
392 JOINT SWELLING 1388 0.0115
393 PULMONARY MASS 171 0.0115
394 BLOOD POTASSIUM DECREASED 345 0.0115
395 LIVER FUNCTION TEST INCREASED 246 0.0114
396 DECREASED APPETITE 2659 0.0114
397 MUSCULOSKELETAL CHEST PAIN 177 0.0114
398 ANAEMIA 2181 0.0114
399 CHOLELITHIASIS 375 0.0114
400 RESPIRATORY DISORDER 342 0.0114
401 URINARY TRACT INFECTION 1948 0.0114
402 SYNCOPE 1142 0.0114
403 FLUSHING 1156 0.0114
404 PALLOR 309 0.0113
405 HEART RATE INCREASED 1120 0.0113
406 ATRIOVENTRICULAR BLOCK 87 0.0112
407 HAEMORRHOIDS 219 0.0112
408 INTENTIONAL PRODUCT USE ISSUE 982 0.0112
409 DYSPNOEA 6344 0.0112
410 SKIN ULCER 289 0.0112
411 NERVE COMPRESSION 103 0.0111
412 MYOSITIS 100 0.0111
413 ALOPECIA 2183 0.0111
414 INJECTION SITE IRRITATION 141 0.0111
415 BLOOD PRESSURE INCREASED 1693 0.0111
416 COUGH 3105 0.0111
417 INFUSION RELATED REACTION 733 0.0110
418 PERICARDIAL EFFUSION 255 0.0110
419 BODY TEMPERATURE INCREASED 225 0.0110
420 PRESYNCOPE 268 0.0110
421 FOOT DEFORMITY 122 0.0110
422 LOWER GASTROINTESTINAL HAEMORRHAGE 81 0.0109
423 ACUTE RESPIRATORY FAILURE 210 0.0109
424 PELVIC FRACTURE 85 0.0109
425 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 569 0.0109
426 ASPHYXIA 89 0.0109
427 INCREASED TENDENCY TO BRUISE 100 0.0109
428 GALLBLADDER DISORDER 194 0.0109
429 MUSCULOSKELETAL DISCOMFORT 187 0.0109
430 DIVERTICULITIS 301 0.0109
431 OXYGEN SATURATION DECREASED 610 0.0108
432 GASTROENTERITIS 158 0.0108
433 MYOCARDIAL ISCHAEMIA 123 0.0108
434 FREQUENT BOWEL MOVEMENTS 291 0.0108
435 UPPER GASTROINTESTINAL HAEMORRHAGE 181 0.0107
436 SUPRAVENTRICULAR TACHYCARDIA 103 0.0107
437 RHINORRHOEA 695 0.0107
438 CLOSTRIDIUM DIFFICILE COLITIS 114 0.0107
439 EAR INFECTION 286 0.0107
440 INSURANCE ISSUE 164 0.0107
441 TOXIC SKIN ERUPTION 108 0.0107
442 HAEMOGLOBIN DECREASED 1100 0.0107
443 URINARY INCONTINENCE 317 0.0107
444 ANURIA 92 0.0107
445 FATIGUE 8321 0.0107
446 INJURY 750 0.0107
447 HYPERHIDROSIS 1374 0.0107
448 BLOOD COUNT ABNORMAL 161 0.0106
449 MEMORY IMPAIRMENT 1458 0.0106
450 POLYNEUROPATHY 127 0.0106
451 RASH PRURITIC 574 0.0106
452 MELAENA 233 0.0106
453 THROAT IRRITATION 475 0.0106
454 BLADDER DISORDER 105 0.0106
455 SOPOR 140 0.0106
456 BRONCHITIS 782 0.0106
457 ASPARTATE AMINOTRANSFERASE INCREASED 561 0.0106
458 ARRHYTHMIA 500 0.0105
459 DYSPHONIA 617 0.0105
460 HEART RATE IRREGULAR 238 0.0105
461 DYSPEPSIA 1036 0.0105
462 MYASTHENIA GRAVIS 85 0.0105
463 TASTE DISORDER 213 0.0105
464 SWELLING 980 0.0105
465 HAEMATEMESIS 265 0.0104
466 MATERNAL DRUGS AFFECTING FOETUS 80 0.0104
467 PULMONARY EMBOLISM 990 0.0104
468 BURNING SENSATION 729 0.0104
469 CARDIAC FAILURE 833 0.0104
470 HYPOAESTHESIA 1552 0.0104
471 IMPAIRED QUALITY OF LIFE 149 0.0104
472 FLANK PAIN 97 0.0103
473 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 736 0.0103
474 TORSADE DE POINTES 81 0.0103
475 SLUGGISHNESS 105 0.0103
476 CATARACT 613 0.0103
477 PYELONEPHRITIS 89 0.0103
478 WEIGHT DECREASED 2865 0.0103
479 ALANINE AMINOTRANSFERASE INCREASED 630 0.0103
480 HEADACHE 6428 0.0102
481 DIARRHOEA 6612 0.0102
482 MULTI-ORGAN FAILURE 177 0.0102
483 DIZZINESS 5097 0.0102
484 ESCHERICHIA INFECTION 84 0.0102
485 SUDDEN DEATH 108 0.0102
486 HEAD INJURY 323 0.0102
487 BLOOD CREATINE PHOSPHOKINASE INCREASED 293 0.0102
488 CHEST DISCOMFORT 1041 0.0102
489 FEELING HOT 622 0.0101
490 RED BLOOD CELL COUNT DECREASED 290 0.0101
491 FULL BLOOD COUNT DECREASED 204 0.0101
492 ATAXIA 120 0.0101
493 RESTLESSNESS 370 0.0101
494 NASOPHARYNGITIS 1861 0.0101
495 BLOOD PRESSURE DECREASED 670 0.0101
496 DYSPHAGIA 957 0.0101
497 BLOOD PRESSURE FLUCTUATION 241 0.0100
498 ORAL CANDIDIASIS 132 0.0100
499 DEEP VEIN THROMBOSIS 651 0.0100
500 EPISTAXIS 749 0.0100
501 POOR QUALITY SLEEP 215 0.0100
502 PERIPHERAL COLDNESS 137 0.0100
503 BLOOD LACTATE DEHYDROGENASE INCREASED 158 0.0100
504 NOCTURIA 121 0.0100
505 INSOMNIA 2654 0.0100
506 MIDDLE INSOMNIA 186 0.0100
507 PARKINSONISM 97 0.0099
508 PAIN IN EXTREMITY 2927 0.0099
509 NECK PAIN 555 0.0099
510 GASTROINTESTINAL INFECTION 89 0.0099
511 ANXIETY 2825 0.0099
512 FEELING COLD 276 0.0099
513 JOINT STIFFNESS 260 0.0099
514 SECRETION DISCHARGE 124 0.0099
515 RIB FRACTURE 203 0.0099
516 PYREXIA 3413 0.0099
517 NEPHROPATHY 92 0.0098
518 WEIGHT INCREASED 2198 0.0098
519 BACK PAIN 2280 0.0098
520 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 168 0.0098
521 ACCIDENTAL OVERDOSE 358 0.0098
522 MUSCLE SPASMS 1795 0.0098
523 PARAESTHESIA 1536 0.0098
524 LABORATORY TEST ABNORMAL 288 0.0097
525 FOOT FRACTURE 185 0.0097
526 BODY TEMPERATURE DECREASED 96 0.0097
527 PANCREATITIS ACUTE 219 0.0097
528 CELLULITIS 491 0.0097
529 LUNG INFILTRATION 86 0.0097
530 VOMITING 4552 0.0097
531 FOETAL EXPOSURE DURING PREGNANCY 787 0.0097
532 ANAL INCONTINENCE 87 0.0097
533 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 225 0.0096
534 MENTAL STATUS CHANGES 268 0.0096
535 LETHARGY 554 0.0096
536 CAESAREAN SECTION 112 0.0096
537 ARTHRALGIA 3999 0.0096
538 LEUKOPENIA 481 0.0096
539 ECZEMA 503 0.0096
540 FEMUR FRACTURE 297 0.0096
541 COVID-19 1682 0.0096
542 BRAIN FOG 150 0.0096
543 UNRESPONSIVE TO STIMULI 247 0.0096
544 METABOLIC ACIDOSIS 306 0.0096
545 INCONTINENCE 101 0.0095
546 ACUTE CORONARY SYNDROME 79 0.0095
547 HAEMODIALYSIS 80 0.0095
548 CHROMATURIA 215 0.0095
549 HYPOTONIA 95 0.0095
550 PLATELET COUNT INCREASED 124 0.0095
551 INJECTION SITE HAEMATOMA 138 0.0095
552 TOOTH INFECTION 125 0.0095
553 OSTEOPOROSIS 390 0.0095
554 CHOLESTASIS 182 0.0095
555 JAUNDICE 255 0.0095
556 ILL-DEFINED DISORDER 575 0.0095
557 LEUKOCYTOSIS 170 0.0094
558 HYPOTHERMIA 95 0.0094
559 HALLUCINATION, VISUAL 198 0.0094
560 CONDITION AGGRAVATED 2850 0.0094
561 GENERALISED OEDEMA 116 0.0094
562 MALAISE 4100 0.0093
563 PULMONARY CONGESTION 123 0.0093
564 THYROID CANCER 112 0.0093
565 RENAL IMPAIRMENT 781 0.0093
566 MYALGIA 1580 0.0093
567 TREMOR 1542 0.0093
568 BLOOD IRON DECREASED 110 0.0093
569 TACHYPNOEA 126 0.0093
570 IMMUNODEFICIENCY 138 0.0092
571 EAR DISCOMFORT 95 0.0092
572 DRUG TOXICITY 126 0.0092
573 VITAMIN D DECREASED 79 0.0092
574 NAUSEA 7290 0.0092
575 PRODUCT ADMINISTRATION ERROR 186 0.0092
576 RESTLESS LEGS SYNDROME 167 0.0092
577 SOMNOLENCE 1849 0.0092
578 FEELING JITTERY 175 0.0092
579 JOINT INJURY 196 0.0092
580 CARDIAC FAILURE CONGESTIVE 736 0.0092
581 SINUS TACHYCARDIA 130 0.0091
582 VISUAL IMPAIRMENT 1134 0.0091
583 PNEUMONIA 2962 0.0091
584 WHITE BLOOD CELL COUNT INCREASED 351 0.0091
585 OROPHARYNGEAL PAIN 846 0.0091
586 BASAL CELL CARCINOMA 142 0.0091
587 PRURITUS 3495 0.0091
588 LACTIC ACIDOSIS 294 0.0091
589 HEAD DISCOMFORT 160 0.0090
590 URINE OUTPUT DECREASED 79 0.0090
591 LACRIMATION INCREASED 273 0.0090
592 EMPHYSEMA 91 0.0090
593 NIGHTMARE 312 0.0090
594 BLOOD PRESSURE ABNORMAL 179 0.0090
595 COAGULOPATHY 150 0.0090
596 EPILEPSY 275 0.0090
597 CORONARY ARTERY DISEASE 272 0.0090
598 AGEUSIA 224 0.0090
599 HEART RATE DECREASED 315 0.0090
600 PANCREATITIS 474 0.0090
601 DEPRESSED MOOD 474 0.0090
602 APHONIA 125 0.0089
603 INFECTION 1296 0.0089
604 EYE INFECTION 101 0.0089
605 MATERNAL EXPOSURE DURING PREGNANCY 797 0.0089
606 ABDOMINAL PAIN 2079 0.0089
607 ULCER 142 0.0089
608 FLATULENCE 506 0.0089
609 PAIN IN JAW 252 0.0089
610 MYOCLONUS 106 0.0089
611 FLUID RETENTION 452 0.0089
612 INFLUENZA LIKE ILLNESS 731 0.0089
613 GAIT DISTURBANCE 1695 0.0088
614 ACUTE MYOCARDIAL INFARCTION 261 0.0088
615 BLOOD BILIRUBIN INCREASED 239 0.0088
616 ECONOMIC PROBLEM 134 0.0088
617 CHOLECYSTECTOMY 101 0.0088
618 ABDOMINAL PAIN LOWER 223 0.0088
619 RETCHING 188 0.0088
620 FEELING ABNORMAL 2108 0.0088
621 IMPAIRED WORK ABILITY 188 0.0088
622 THIRST 157 0.0088
623 INTERVERTEBRAL DISC PROTRUSION 192 0.0088
624 NEURALGIA 213 0.0088
625 HYPOKINESIA 127 0.0087
626 HERNIA 169 0.0087
627 SKIN INFECTION 98 0.0087
628 GASTRIC ULCER 166 0.0087
629 PAIN 5349 0.0087
630 LYMPHOPENIA 123 0.0087
631 HYPERSOMNIA 249 0.0087
632 HEPATITIS 222 0.0087
633 WRIST FRACTURE 104 0.0087
634 MALNUTRITION 97 0.0087
635 SENSORY DISTURBANCE 139 0.0087
636 PANCYTOPENIA 484 0.0087
637 HEPATOMEGALY 85 0.0086
638 PNEUMONIA ASPIRATION 216 0.0086
639 DYSURIA 318 0.0086
640 SPINAL FRACTURE 173 0.0086
641 PRODUCT DISTRIBUTION ISSUE 80 0.0086
642 PLATELET COUNT DECREASED 918 0.0086
643 LOCALISED INFECTION 208 0.0086
644 DYSSTASIA 251 0.0086
645 RENAL FAILURE 1139 0.0086
646 HOT FLUSH 645 0.0085
647 AGRANULOCYTOSIS 159 0.0085
648 GASTROINTESTINAL PAIN 94 0.0085
649 NASAL CONGESTION 502 0.0085
650 THROMBOCYTOPENIA 953 0.0085
651 APATHY 124 0.0085
652 EJECTION FRACTION DECREASED 132 0.0085
653 BLOOD TRIGLYCERIDES INCREASED 150 0.0085
654 HIP FRACTURE 273 0.0085
655 SEROTONIN SYNDROME 163 0.0085
656 DEPRESSION 1930 0.0085
657 PHARMACEUTICAL PRODUCT COMPLAINT 220 0.0085
658 TOOTH FRACTURE 93 0.0084
659 RASH MACULO-PAPULAR 187 0.0084
660 ANKLE FRACTURE 130 0.0084
661 SALIVARY HYPERSECRETION 84 0.0084
662 EOSINOPHILIA 147 0.0084
663 SUBDURAL HAEMATOMA 120 0.0084
664 SKIN REACTION 118 0.0084
665 BACK INJURY 91 0.0084
666 EYE SWELLING 311 0.0084
667 KIDNEY INFECTION 164 0.0083
668 ISCHAEMIC STROKE 149 0.0083
669 PNEUMONITIS 227 0.0083
670 ABDOMINAL DISTENSION 870 0.0083
671 HYPERSENSITIVITY 1546 0.0083
672 DYSGEUSIA 617 0.0083
673 PHARYNGITIS 103 0.0083
674 FACE OEDEMA 140 0.0083
675 DEMENTIA 232 0.0083
676 COLD SWEAT 146 0.0083
677 VENTRICULAR FIBRILLATION 92 0.0083
678 MUSCLE RIGIDITY 99 0.0083
679 LOSS OF CONSCIOUSNESS 1060 0.0083
680 URINARY RETENTION 276 0.0083
681 CONVULSION 473 0.0083
682 MANIA 136 0.0083
683 THROMBOSIS 665 0.0083
684 ABASIA 204 0.0082
685 WHITE BLOOD CELL COUNT DECREASED 889 0.0082
686 PULMONARY OEDEMA 367 0.0082
687 DRY SKIN 1093 0.0082
688 TREATMENT NONCOMPLIANCE 445 0.0081
689 EYE DISORDER 267 0.0081
690 CANDIDA INFECTION 137 0.0081
691 SPLENOMEGALY 95 0.0081
692 BONE PAIN 475 0.0081
693 GASTROENTERITIS VIRAL 146 0.0081
694 EYE DISCHARGE 84 0.0081
695 POST PROCEDURAL COMPLICATION 155 0.0081
696 FAECES DISCOLOURED 175 0.0081
697 ADVERSE DRUG REACTION 724 0.0081
698 SCAR 138 0.0081
699 ACUTE RESPIRATORY DISTRESS SYNDROME 142 0.0080
700 CARDIAC DISORDER 751 0.0080
701 DRY EYE 399 0.0080
702 INFLUENZA 891 0.0080
703 AGITATION 586 0.0080
704 GLAUCOMA 153 0.0079
705 CHILLS 931 0.0079
706 COLITIS 301 0.0079
707 BACK DISORDER 129 0.0079
708 CARDIOMYOPATHY 117 0.0079
709 RASH 3450 0.0079
710 POLLAKIURIA 330 0.0079
711 LIGAMENT SPRAIN 78 0.0079
712 DIABETES MELLITUS 601 0.0079
713 ROTATOR CUFF SYNDROME 101 0.0079
714 TOOTH ABSCESS 80 0.0078
715 ORAL DISCOMFORT 109 0.0078
716 OSTEOPENIA 119 0.0078
717 NEUROLEPTIC MALIGNANT SYNDROME 93 0.0078
718 SKIN FISSURES 153 0.0078
719 BACTERIAL INFECTION 146 0.0078
720 ENCEPHALOPATHY 192 0.0078
721 ILEUS 97 0.0078
722 LIMB INJURY 212 0.0078
723 PULMONARY THROMBOSIS 85 0.0078
724 SKIN EXFOLIATION 657 0.0078
725 BRAIN OEDEMA 98 0.0078
726 LIMB DISCOMFORT 239 0.0077
727 SEPTIC SHOCK 336 0.0077
728 SWELLING FACE 502 0.0077
729 ACTIVITIES OF DAILY LIVING IMPAIRED 152 0.0077
730 SEPSIS 855 0.0077
731 HEPATIC FAILURE 231 0.0077
732 EYELID OEDEMA 89 0.0076
733 HAEMATURIA 262 0.0076
734 RASH MACULAR 267 0.0076
735 TRANSFUSION 80 0.0076
736 VIRAL INFECTION 254 0.0076
737 INTENTIONAL PRODUCT MISUSE 666 0.0076
738 DECREASED ACTIVITY 82 0.0076
739 URTICARIA 1273 0.0076
740 DENTAL CARIES 84 0.0076
741 HERPES ZOSTER 435 0.0076
742 TOOTHACHE 137 0.0076
743 PRURITUS GENERALISED 163 0.0075
744 BLOOD URINE PRESENT 143 0.0075
745 HYPOPHAGIA 192 0.0075
746 ILLNESS 772 0.0075
747 BLOOD GLUCOSE FLUCTUATION 82 0.0075
748 PSYCHOMOTOR HYPERACTIVITY 124 0.0075
749 GASTROINTESTINAL HAEMORRHAGE 619 0.0074
750 PROTEINURIA 140 0.0074
751 ACUTE KIDNEY INJURY 1126 0.0074
752 VISION BLURRED 1007 0.0073
753 MUCOSAL INFLAMMATION 192 0.0073
754 CYST 91 0.0073
755 TOOTH DISORDER 163 0.0073
756 RESPIRATORY DISTRESS 202 0.0073
757 SMALL INTESTINAL OBSTRUCTION 90 0.0073
758 BLOOD GLUCOSE INCREASED 1374 0.0073
759 NERVOUSNESS 381 0.0073
760 EXPOSURE DURING PREGNANCY 453 0.0073
761 THROAT TIGHTNESS 197 0.0073
762 FEEDING DISORDER 147 0.0072
763 ASCITES 213 0.0072
764 LYMPHOCYTE COUNT DECREASED 128 0.0072
765 PRODUCT DOSE OMISSION IN ERROR 205 0.0072
766 TENDONITIS 112 0.0072
767 BEDRIDDEN 95 0.0072
768 RESPIRATORY FAILURE 527 0.0072
769 MUSCLE TIGHTNESS 117 0.0072
770 PHARYNGEAL OEDEMA 111 0.0072
771 PRODUCT SUBSTITUTION ISSUE 415 0.0072
772 NEUROPATHY PERIPHERAL 685 0.0072
773 SPEECH DISORDER 377 0.0072
774 METASTASES TO LUNG 83 0.0072
775 DISABILITY 142 0.0072
776 GINGIVAL BLEEDING 98 0.0072
777 PULMONARY ARTERIAL HYPERTENSION 104 0.0072
778 BIPOLAR DISORDER 78 0.0072
779 HALLUCINATION, AUDITORY 114 0.0072
780 CORONARY ARTERY OCCLUSION 98 0.0071
781 MOUTH ULCERATION 150 0.0071
782 CONJUNCTIVITIS 132 0.0071
783 INTERSTITIAL LUNG DISEASE 344 0.0071
784 PHOTOSENSITIVITY REACTION 117 0.0071
785 STAPHYLOCOCCAL INFECTION 233 0.0071
786 DYSKINESIA 287 0.0071
787 DIALYSIS 100 0.0070
788 UPPER LIMB FRACTURE 140 0.0070
789 GASTRIC DISORDER 241 0.0070
790 VISUAL ACUITY REDUCED 233 0.0070
791 RASH ERYTHEMATOUS 332 0.0069
792 PARAESTHESIA ORAL 100 0.0069
793 CHOKING 135 0.0069
794 RASH GENERALISED 178 0.0069
795 PNEUMOTHORAX 109 0.0069
796 BRONCHOSPASM 98 0.0069
797 SKIN LESION 188 0.0068
798 TREATMENT FAILURE 567 0.0068
799 ERUCTATION 132 0.0068
800 EYE IRRITATION 391 0.0068
801 PRODUCT USE COMPLAINT 107 0.0068
802 MOVEMENT DISORDER 218 0.0068
803 CEREBROVASCULAR ACCIDENT 1145 0.0068
804 DRUG-INDUCED LIVER INJURY 212 0.0068
805 METASTASES TO CENTRAL NERVOUS SYSTEM 87 0.0067
806 CEREBRAL HAEMORRHAGE 241 0.0067
807 DRUG ERUPTION 119 0.0067
808 DELUSION 104 0.0067
809 DERMATITIS ALLERGIC 84 0.0067
810 EYE HAEMORRHAGE 89 0.0067
811 TOOTH EXTRACTION 83 0.0067
812 OCULAR HYPERAEMIA 316 0.0067
813 TENDON RUPTURE 82 0.0066
814 FEAR 178 0.0066
815 ORAL HERPES 129 0.0066
816 THINKING ABNORMAL 123 0.0066
817 MASS 92 0.0066
818 LYMPHADENOPATHY 233 0.0066
819 HEPATIC CYTOLYSIS 83 0.0065
820 INCREASED APPETITE 124 0.0065
821 PANIC ATTACK 236 0.0065
822 PRODUCT USE ISSUE 1215 0.0065
823 TOXIC EPIDERMAL NECROLYSIS 98 0.0064
824 IMMUNE SYSTEM DISORDER 85 0.0064
825 FEBRILE NEUTROPENIA 423 0.0064
826 COLITIS ULCERATIVE 284 0.0063
827 NEPHROLITHIASIS 291 0.0063
828 MYOCARDIAL INFARCTION 1105 0.0063
829 PRODUCT DOSE OMISSION ISSUE 1862 0.0063
830 ABSCESS 101 0.0063
831 SKIN DISORDER 211 0.0063
832 DEAFNESS 165 0.0063
833 CYANOSIS 99 0.0063
834 FUNGAL INFECTION 209 0.0063
835 END STAGE RENAL DISEASE 114 0.0062
836 MUSCLE ATROPHY 79 0.0062
837 SKIN DISCOLOURATION 285 0.0062
838 ERYTHEMA 1272 0.0062
839 BLOOD GLUCOSE DECREASED 297 0.0062
840 FRACTURE 117 0.0062
841 SHOCK 142 0.0062
842 MYDRIASIS 79 0.0062
843 THERAPEUTIC RESPONSE DECREASED 373 0.0061
844 CARDIOGENIC SHOCK 88 0.0061
845 NEOPLASM PROGRESSION 213 0.0061
846 DISSEMINATED INTRAVASCULAR COAGULATION 86 0.0061
847 ACUTE HEPATIC FAILURE 83 0.0061
848 COMA 289 0.0061
849 IRRITABILITY 364 0.0060
850 BONE DISORDER 110 0.0060
851 PARANOIA 104 0.0060
852 DRUG EFFECT LESS THAN EXPECTED 89 0.0060
853 ALTERED STATE OF CONSCIOUSNESS 130 0.0060
854 LYMPHOMA 92 0.0059
855 WRONG TECHNIQUE IN DRUG USAGE PROCESS 215 0.0059
856 TOXICITY TO VARIOUS AGENTS 998 0.0059
857 CEREBRAL INFARCTION 144 0.0059
858 STEVENS-JOHNSON SYNDROME 131 0.0059
859 ADVERSE EVENT 542 0.0059
860 INTENTIONAL DOSE OMISSION 167 0.0059
861 OSTEOMYELITIS 106 0.0058
862 DEVICE RELATED INFECTION 90 0.0058
863 HYPOACUSIS 251 0.0058
864 MOOD ALTERED 159 0.0058
865 HAEMORRHAGE INTRACRANIAL 87 0.0058
866 NEUTROPHIL COUNT DECREASED 237 0.0058
867 PRODUCT USE IN UNAPPROVED INDICATION 1438 0.0058
868 THERAPY PARTIAL RESPONDER 90 0.0058
869 CARDIAC ARREST 472 0.0057
870 HUNGER 79 0.0057
871 NEUTROPENIA 762 0.0056
872 COMPLETED SUICIDE 466 0.0056
873 HYPOAESTHESIA ORAL 84 0.0056
874 COLON CANCER 83 0.0056
875 ABNORMAL BEHAVIOUR 219 0.0055
876 CRYING 200 0.0055
877 DIABETIC KETOACIDOSIS 132 0.0055
878 MYELODYSPLASTIC SYNDROME 79 0.0055
879 MULTIPLE SCLEROSIS 260 0.0054
880 DRUG EXPOSURE DURING PREGNANCY 183 0.0054
881 OSTEONECROSIS OF JAW 133 0.0054
882 BLOOD GLUCOSE ABNORMAL 99 0.0054
883 ACUTE MYELOID LEUKAEMIA 83 0.0053
884 ABNORMAL DREAMS 146 0.0053
885 PREMATURE BABY 159 0.0053
886 METASTASES TO BONE 86 0.0052
887 CARDIOVASCULAR DISORDER 133 0.0052
888 RESPIRATORY ARREST 143 0.0052
889 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 930 0.0052
890 MENTAL IMPAIRMENT 125 0.0052
891 UNEVALUABLE EVENT 388 0.0051
892 CLOSTRIDIUM DIFFICILE INFECTION 111 0.0051
893 INTESTINAL OBSTRUCTION 191 0.0051
894 METASTASES TO LIVER 89 0.0051
895 INJECTION SITE PRURITUS 339 0.0051
896 DYSTONIA 98 0.0050
897 ANAPHYLACTIC SHOCK 130 0.0050
898 AGGRESSION 251 0.0050
899 THERAPEUTIC RESPONSE UNEXPECTED 225 0.0050
900 HEPATIC FUNCTION ABNORMAL 186 0.0050
901 ANAPHYLACTIC REACTION 275 0.0050
902 CARDIO-RESPIRATORY ARREST 208 0.0050
903 DERMATITIS 104 0.0050
904 MENTAL DISORDER 215 0.0049
905 HAEMORRHAGE 515 0.0049
906 MALIGNANT NEOPLASM PROGRESSION 497 0.0048
907 CHRONIC KIDNEY DISEASE 368 0.0048
908 EMOTIONAL DISORDER 148 0.0048
909 GLYCOSYLATED HAEMOGLOBIN INCREASED 121 0.0048
910 DRUG PRESCRIBING ERROR 92 0.0048
911 PERITONITIS 99 0.0048
912 OFF LABEL USE 4143 0.0047
913 DRUG EFFECT DECREASED 254 0.0047
914 INJECTION SITE RASH 144 0.0047
915 OSTEONECROSIS 154 0.0047
916 INTENTIONAL DRUG MISUSE 98 0.0047
917 INJECTION SITE ERYTHEMA 580 0.0047
918 SUICIDE ATTEMPT 277 0.0046
919 HEPATOTOXICITY 101 0.0045
920 SUICIDAL IDEATION 414 0.0045
921 MOOD SWINGS 144 0.0045
922 PSYCHOTIC DISORDER 133 0.0045
923 SURGERY 264 0.0045
924 PSORIASIS 588 0.0045
925 HOSPITALISATION 687 0.0045
926 INTENTIONAL SELF-INJURY 90 0.0045
927 PRODUCT DOSE OMISSION 288 0.0044
928 INJECTION SITE WARMTH 90 0.0044
929 MUSCULOSKELETAL DISORDER 83 0.0044
930 BONE MARROW FAILURE 88 0.0043
931 MULTIPLE ORGAN DYSFUNCTION SYNDROME 121 0.0043
932 DISEASE PROGRESSION 503 0.0042
933 NERVOUS SYSTEM DISORDER 132 0.0042
934 PLASMA CELL MYELOMA 165 0.0042
935 PRODUCT DISPENSING ERROR 91 0.0042
936 PRODUCT AVAILABILITY ISSUE 95 0.0042
937 THERAPY INTERRUPTED 298 0.0042
938 RENAL INJURY 123 0.0041
939 DRUG INEFFECTIVE 5446 0.0041
940 INTENTIONAL OVERDOSE 265 0.0041
941 DRUG ADMINISTRATION ERROR 126 0.0041
942 ANGER 137 0.0040
943 DISEASE RECURRENCE 192 0.0040
944 ANHEDONIA 105 0.0040
945 SEIZURE 459 0.0040
946 SKIN CANCER 84 0.0039
947 DEVICE DISLOCATION 168 0.0039
948 INCORRECT DOSE ADMINISTERED 882 0.0039
949 EXPOSURE VIA SKIN CONTACT 100 0.0039
950 WITHDRAWAL SYNDROME 161 0.0038
951 PRODUCT QUALITY ISSUE 515 0.0038
952 INJECTION SITE REACTION 259 0.0038
953 NEOPLASM MALIGNANT 248 0.0037
954 LUNG NEOPLASM MALIGNANT 152 0.0037
955 INJECTION SITE SWELLING 282 0.0037
956 INCORRECT DRUG ADMINISTRATION DURATION 102 0.0036
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 255 0.0036
958 MULTIPLE SCLEROSIS RELAPSE 244 0.0036
959 UNDERDOSE 257 0.0035
960 BREAST CANCER FEMALE 94 0.0035
961 OVERDOSE 754 0.0035
962 INJECTION SITE PAIN 1069 0.0035
963 NO ADVERSE EVENT 625 0.0034
964 TARDIVE DYSKINESIA 97 0.0034
965 VAGINAL HAEMORRHAGE 146 0.0034
966 DRUG DOSE OMISSION 551 0.0033
967 THERAPEUTIC RESPONSE SHORTENED 110 0.0033
968 PROCEDURAL PAIN 90 0.0032
969 INJECTION SITE URTICARIA 78 0.0032
970 DRUG ABUSE 261 0.0031
971 INJECTION SITE HAEMORRHAGE 244 0.0031
972 APPLICATION SITE ERYTHEMA 80 0.0030
973 SKIN BURNING SENSATION 218 0.0030
974 DERMATITIS ATOPIC 160 0.0030
975 DEATH 2549 0.0030
976 ABORTION SPONTANEOUS 118 0.0029
977 INJECTION SITE MASS 108 0.0029
978 MYELOSUPPRESSION 104 0.0029
979 INJECTION SITE BRUISING 230 0.0029
980 THERAPY CESSATION 143 0.0028
981 EMOTIONAL DISTRESS 329 0.0027
982 DEVICE MALFUNCTION 188 0.0027
983 BREAST CANCER 248 0.0027
984 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 130 0.0024
985 DRUG WITHDRAWAL SYNDROME 205 0.0023
986 SKIN IRRITATION 104 0.0023
987 EXTRA DOSE ADMINISTERED 91 0.0022
988 ACNE 165 0.0022
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 435 0.0021
990 DEVICE ISSUE 188 0.0021
991 DEVICE BREAKAGE 78 0.0019
992 ACCIDENTAL EXPOSURE TO PRODUCT 151 0.0015
993 PRODUCT STORAGE ERROR 93 0.0011
994 DRUG DEPENDENCE 144 0.0009